Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-389563

Tenaya Therapeutics, Inc. · TNYA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Faraz Ali
Officer — Chief Executive Officer · Director
Period of report
Sep 10, 2026
Accepted (ET)
Sep 11, 2026 · 8:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001858848

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Sep 10, 2026A122,000$0.00A539,782D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to buy)F4$0.6488Sep 10, 2026A732,500AOct 10, 2026Sep 9, 2036Common Stock732,500732,500D

Explanation of responses